The prefrontal cortex, known for its integral role in executive functions such as decision making, social behavior, and cognitive flexibility, has long fascinated neuroscientists. Despite its critical importance, the precise temporal and spatial dynamics of molecular changes leading to its mature state have remained elusive. This study moves the field forward by harnessing multi-omic single-cell technologies to capture the nuances of both transcriptomic and chromatin landscapes as development progresses.

At the heart of this investigation lies the innovative integration of spatial transcriptomics with chromatin accessibility assays performed at the single-cell level. By doing so, the researchers have been able to correlate gene expression states with the underlying epigenetic architecture across discrete developmental time points and in the detailed anatomical context of the developing cortex. This dual approach enables an unprecedented resolution of how cellular identities are established and maintained during critical periods of brain maturation.

The researchers focused their analysis on postnatal stages — a period marked by rapid and dynamic restructuring of neural circuits. Their choice to include both human and macaque brains in the study further allows for comparative insights, enhancing our understanding of species-specific versus conserved developmental mechanisms. Such comparative work is especially important given the evolutionary proximity of macaques to humans and their widespread use as models for human brain function and disorders.

One of the most compelling findings revealed distinct trajectories of gene expression programs that are tightly coupled with changes in chromatin accessibility. This coupling appears to orchestrate the differentiation and specialization of cortical neurons and glial cells, highlighting the complexity of gene regulatory networks at play. These gene networks underpin defining features of cortical circuitry, including the establishment of synaptic connections and the pruning processes essential for functional maturation.

Moreover, the spatial dimension of the data unveiled intriguing region-specific patterns. Different prefrontal cortical subregions showed unique molecular signatures and epigenomic states, which likely correspond to their specialized roles within the wider prefrontal network. This spatial heterogeneity underscores the importance of studying brain development within an anatomical framework, as opposed to bulk analyses that often obscure such fine-grained regional distinctions.

Chromatin accessibility profiling illuminated critical zones of regulatory elements—enhancers and promoters—that dynamically change their activity during key developmental windows. Understanding when and where these regulatory elements operate provides vital clues into how transcriptional programs are modulated and how disruptions in these processes could lead to neurodevelopmental disorders.

The data also highlighted cellular heterogeneity and lineage relationships within the developing cortex. By mapping single-cell transcriptomes alongside chromatin states, the team could reconstruct developmental trajectories and pinpoint critical decision points where progenitor cells diverge into specific cortical neuron subtypes. This molecular roadmap beautifully illustrates the stepwise maturation process and could inform strategies for therapeutic interventions or stem cell-based regenerative approaches.

Importantly, the study offers a critical resource: an integrated spatiotemporal atlas of transcriptomic and epigenetic landscapes in the developing primate brain. This reference atlas stands to profoundly impact future efforts to understand neurodevelopmental disorders such as autism spectrum disorder, schizophrenia, and other cognitive dysfunctions rooted in early brain development. It provides a benchmark against which pathological changes can be measured.

In terms of methodology, the combination of high-throughput sequencing technologies and spatial transcriptomics platforms represents a powerful convergence of technological advances. These approaches allow not only the profiling of thousands of individual cells but also their localization within intact tissue architecture. The researchers’ data analysis pipeline, leveraging advanced computational frameworks, ensures robust integration and interpretation of these complex datasets.

Additionally, by studying both human and macaque postnatal development, the authors contribute to evolutionary neuroscience. Their comparative approach enables identification of conserved regulatory circuits as well as species-specific adaptations that may underlie unique cognitive and behavioral traits of primates. This sets the stage for unraveling the evolutionary pressures shaping higher-order brain functions.

This work also has implications for understanding the timing of critical developmental periods. The spatiotemporal maps provide insights into when certain gene regulatory programs are activated or repressed, which correlates with known windows of heightened plasticity and vulnerability in the prefrontal cortex. Such knowledge could inform the timing of interventions to optimize neurodevelopmental outcomes.

Notably, the dual focus on transcriptomics and chromatin accessibility helps disentangle cause-and-effect relationships, clarifying whether gene expression changes are driven by epigenetic remodeling or vice versa. This mechanistic clarity goes beyond correlation and lays the groundwork for targeted manipulation of gene regulatory elements in future studies.

While the study concentrates on the postnatal phase, the authors acknowledge that extending these analyses to prenatal stages and later adulthood could provide a full developmental continuum. Moreover, including pathological samples from individuals with neurodevelopmental disorders could reveal specific molecular derailments contributing to disease.

In summary, this landmark study pushes the frontier of brain developmental biology by integrating spatial and temporal dimensions of gene regulation at single-cell resolution in primates. The resulting comprehensive atlas of transcriptomic and chromatin accessibility landscapes in the postnatal prefrontal cortex offers a transformative tool for neuroscience research, with far-reaching implications for understanding brain evolution, development, and disease.

The findings highlight the intricate choreography of genetic and epigenetic factors guiding the maturation of the prefrontal cortex. This work not only deepens our insight into fundamental brain biology but also underscores the power of multi-omic single-cell approaches to unlock the mysteries of complex neuronal systems. As the field continues to evolve, such integrative studies are poised to reshape our understanding of the brain’s developmental blueprint and open new avenues for therapeutic innovation.

Subject of Research: Postnatal development of the human and macaque prefrontal cortex using single-cell transcriptomics and chromatin accessibility profiling.

Article Title: Single-cell spatiotemporal transcriptomic and chromatin accessibility profiling in developing postnatal human and macaque prefrontal cortex.

Article References:
Zhang, J., Li, M., Wang, M. et al. Single-cell spatiotemporal transcriptomic and chromatin accessibility profiling in developing postnatal human and macaque prefrontal cortex. Nat Neurosci (2025). https://doi.org/10.1038/s41593-025-02150-7

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41593-025-02150-7

Central to this initiative was the use of isogenic human iPSC lines harboring distinct APOE genotypes, notorious for their implication in Alzheimer’s disease risk modulation. Through meticulous cell culture techniques, the investigators generated iPSC-derived neurons, astrocytes, and microglia, ensuring stringent quality control via SNP arrays to monitor genomic integrity and repeated mycoplasma testing. The differentiation protocols were finely tuned, employing transcription factor-driven approaches for neuron induction, neurosphere formation for astrocytes, and embryoid body–based induction for microglia, each optimized to recapitulate key features of their in vivo counterparts.

Lipidomic profiling harnessed a methyl tert-butyl ether (MTBE)-based extraction method combined with advanced liquid chromatography–mass spectrometry (LC-MS) on a Sciex QTrap 5500 platform equipped with differential mobility spectrometry. This enabled precise quantification of a comprehensive panel of lipid species, with the incorporation of 54 deuterated internal standards facilitating robust normalization and quality control. Critically, data analysis incorporated stringent blank filtering and sophisticated bioinformatics tools such as SLA and SODA-Light, which provided interactive visualization and integration of multi-dimensional lipidomics data, enhancing interpretability and fostering data accessibility through the Neurolipid Atlas web portal.

The multi-omics strategy was further exemplified by simultaneous proteomic and transcriptomic analyses derived from matched iAstrocyte populations of APOE3/3 and APOE4/4 genotypes and subjected to reactive and control conditions. Proteomic workflows employed data-independent acquisition on an Orbitrap Exploris 480 mass spectrometer paired with cutting-edge software (Spectronaut version 18) to deliver high-confidence protein quantification with stringent false discovery rates. Meanwhile, transcriptomic sequencing utilized ribosomal RNA–depletion protocols and high-throughput paired-end Illumina sequencing, allowing deep characterization of gene expression changes linked to genotype and inflammatory activation states.

Complementing human cell models, primary mouse astrocyte cultures derived from embryonic and early postnatal cortices were utilized to validate lipidomic signatures and investigate reactive phenotypes under cytokine-induced inflammatory conditions. These in vitro models provided essential cross-species validation and facilitated functional interrogation of lipid remodeling in neuroinflammatory contexts. Notably, the integration of cholesterol metabolism dynamics was probed through methyl-β-cyclodextrin-mediated cholesterol loading and pharmacological modulation with avasimibe and atorvastatin, illustrating nuanced lipid alterations underpinning cellular responses in disease-relevant scenarios.

In parallel to cell culture systems, postmortem brain tissue lipidomics from well-characterized donor cohorts, including Alzheimer’s disease and non-demented control cases, unveiled distinct lipidomic shifts within the frontal cortex and cerebellum. These brain region–specific lipid alterations were meticulously quantified, normalized to tissue homogenate mass, and rigorously controlled for potential confounding variables such as postmortem interval and APOE genotype. This approach illuminated lipid species potentially involved in neurodegenerative processes, offering critical correlations between cellular lipid signatures and disease pathology.

The Neurolipid Atlas notably advances data sharing, with an open-access platform designed to incorporate external lipidomic datasets coupled with standardized metadata formatting to ensure reproducibility and interoperability. This democratization of data invites comprehensive cross-study comparisons and replication, propelling the field toward an integrative systems-level understanding of brain lipid metabolism. By including up-to-date software tools fully available on GitHub, the resource empowers researchers globally to analyze, visualize, and interpret complex lipidomic datasets with enhanced precision.

Methodological rigor permeates every facet of the study, from cell culture to omics data acquisition. iPSC-derived cells underwent rigorous validation including copy-number variation (CNV) analysis to exclude genomic anomalies potentially influencing data integrity. Immunocytochemical assessments ensured high purity of differentiated cells, quantified by automated computational methods leveraging signal-to-noise ratios to distinguish specific marker expression. Flow cytometric analyses further characterized microglial precursors using established surface markers like CD45 and CD11b, guaranteeing the authenticity of cell identities before downstream lipidomic profiling.

The integrative experimental design also incorporated the generation of TMEM106B-knockout neurons, leveraging a genetically engineered iPSC line to probe the influence of this gene—associated with frontotemporal lobar degeneration—on neuronal lipid composition. This element underscored the utility of the Atlas in accommodating diverse genetic backgrounds and pathologies, highlighting its adaptability to study gene-centric lipidomic perturbations relevant to neurodegeneration.

A particular strength of this research lies in the longitudinal and combinatorial analyses conducted on reactive versus control astrocytes. Treatment with a cytokine cocktail containing TNF, IL-1α, and C1q simulated neuroinflammatory stimuli, enabling characterization of lipidomic and proteomic shifts concomitant with astrocyte activation. The data revealed distinct lipid signatures reflective of reactive states, implicating altered phospholipid saturation patterns and cholesterol metabolism in astrocyte-mediated inflammatory responses—a finding with profound implications for understanding the molecular underpinnings of neuroinflammation in disorders such as Alzheimer’s disease.

State-of-the-art analytical techniques were meticulously applied across all data types. Quantitative PCR protocols employed rigorously validated primers and normalization schemes, while western blotting utilized PVDF membranes combined with fluorescence-based detection for sensitive quantification of immune-related protein expression changes. Moreover, the use of multiplex mesoscale discovery immunoassays to quantify secreted cytokines from astrocyte cultures added a vital functional dimension, linking lipid alterations to inflammatory mediator secretion.

In synthesizing lipidomics, proteomics, and transcriptomics data, the Neurolipid Atlas facilitates a holistic view of neurodegenerative disease biology focused on membrane and lipid metabolism alterations. The identification of genotype-dependent differences in lipid saturation and composition, supported by complementary gene expression shifts, exemplifies the depth of insight achievable through multi-omic integration. This resource not only charts fundamental biological processes but also opens new avenues for therapeutic intervention targeting lipid metabolic pathways that have thus far remained elusive in neurodegenerative disease research.

Finally, by establishing standardized, reproducible protocols for sample collection, processing, and analysis, the Neurolipid Atlas sets a new benchmark for rigor in neuro-lipidomics. The careful documentation of culture conditions, cell differentiation timelines, reagent sources, and data normalization methods provides a transparent framework fostering reproducibility and comparability across laboratories. As such, this monumental effort stands to catalyze further longitudinal and translational research initiatives, ultimately fostering breakthroughs in biomarkers, mechanistic understanding, and treatment development for devastating neurological disorders.

Subject of Research: Lipidomic characterization of neurodegenerative diseases using human iPSC-derived brain cells, mouse astrocytes, and postmortem brain tissue with multi-omics integration.

Article Title: The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases.

Article References:
Feringa, F.M., Koppes-den Hertog, S.J., Wang, L.Y. et al. The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases. Nat Metab (2025). https://doi.org/10.1038/s42255-025-01365-z